NOI - Olink Explore HT Proteomic Analysis for Sepsis Biomarker Study
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), intends to award a non-competitive, firm-fixed-price purchase order for high-throughput proteomic analysis services. This opportunity, identified as a Notice of Intent, seeks to support a sepsis biomarker study using the Olink Explore HT platform on plasma samples from a non-human primate septic shock model. While non-competitive, interested parties may submit capability statements. Responses are due by May 13, 2026, 9:00 AM EDT.
Scope of Work
The required services involve comprehensive proteomic profiling utilizing the Olink Explore HT platform with Next Generation Sequencing (NGS)-based readout. The contractor will be responsible for simultaneously quantifying over 5,400 proteins from low-volume plasma samples. Key deliverables include:
- Sample processing and assay execution.
- Rigorous quality control.
- Data normalization and delivery of complete, analysis-ready datasets. The analysis will directly support NHLBI's research into inflammatory biomarkers and therapeutic responses within the non-human primate septic shock model.
Contract Details
- Type: Firm-Fixed-Price Purchase Order.
- Delivery Location: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD.
- NAICS Code: 541380 – Testing Laboratories and Services, with a small business size standard of $19M.
- Set-Aside: None. This is a non-competitive action, with Psomagen, Inc. identified as the only vendor capable of meeting technical requirements without unacceptable risk.
Submission & Evaluation
This is a combined synopsis/solicitation issued non-competitively. A formal written solicitation will not be issued. Interested parties must submit capability statements demonstrating their ability to meet the Government's requirements. Submissions should include:
- Sufficient information to establish bona-fide capabilities.
- Unit price, list price, shipping/handling, delivery days, F.O.B. Point.
- Product details, past performance, and warranty information.
- Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must have an active registration in SAM.gov. Submissions must be sent electronically to nicholas.capobianco@nih.gov.
Key Dates
- Published Date: April 29, 2026.
- Responses Due: May 13, 2026, 9:00 AM EDT.